PubAg

Main content area

Human airway trypsin-like protease enhances interleukin-8 synthesis in bronchial epithelial cells by activating protease-activated receptor 2

Author:
Miki, Mari, Yasuoka, Susumu, Tsutsumi, Rie, Nakamura, Yoichi, Hajime, Maeda, Takeuchi, Yukiyasu, Miki, Keisuke, Kitada, Seigo, Maekura, Ryoji
Source:
Archives of biochemistry and biophysics 2019 v.664 pp. 167-173
ISSN:
0003-9861
Subject:
Northern blotting, enzyme inhibitors, epithelial cells, fluorescent antibody technique, gene expression, humans, inflammation, interleukin-8, messenger RNA, proteinases, respiratory tract diseases, small interfering RNA
Abstract:
Human airway trypsin-like protease (HAT) localizes at human bronchial epithelial cells (HBECs). HAT enhanced release of interleukin-8 (IL-8) from HBECs at 10–100 mU/mL and the enhanced release was almost completely abolished by 50 μM leupeptin, a serine protease inhibitor. Previous reports suggested that HAT displays its physiological functions via protease-activated receptor 2 (PAR2). In the present study, we examined the mechanism whereby HAT upregulates IL-8 synthesis in HBECs with a focus on PAR2. Northern blot analysis revealed that HAT enhanced IL-8 mRNA expression at concentrations of 10–100 mU/mL. PAR2 activating peptide (PAR2 AP) also enhanced IL-8 release and IL-8 mRNA expression in HBECs at 50–1,000 μM at similar levels as HAT. Knockdown of PAR2 mRNA by siRNA methods showed that PAR2 mRNA expression was significantly depressed in primary HBECs, and both HAT- and PAR2 AP-induced IL-8 mRNA elevation was significantly depressed in PAR2 siRNA-transfected HBECs. Additionally, HAT cleaved the PAR2 activating site (R36-S37 bond) of synthetic PAR2 N-terminal peptide. These results indicate that HAT stimulates IL-8 synthesis in airway epithelial cells via PAR2 and could help to amplify inflammation in chronic respiratory tract disease.
Agid:
6280194